Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. - Wikidata - awgldk - TriplyDB

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

http://www.wikidata.org/entity/Q34733886

about

Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings Cardiotoxicity in childhood cancer survivors: strategies for prevention and management Depressogenic effects of medications: a review Liposome-based drug delivery in breast cancer treatment Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors Clinical Translation of Nanomedicine.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study.Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.Delivering nanomedicine to solid tumors.A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma.Liposomally targeted cytotoxic drugs for the treatment of cancer.Therapeutic approaches to AIDS-related malignancies.Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.Biological rationale for the design of polymeric anti-cancer nanomedicines.Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.Design considerations for nanotherapeutics in oncology.Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models.Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007 A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.Liposomal daunorubicin as treatment for Kaposi's sarcoma Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.Targeted therapy for Kaposi sarcoma.Targeted drug delivery strategies to treat lung metastasis.Hepatic Kaposi sarcoma: A case report and review of the literature.Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.New drug targets in Kaposi sarcoma.Pharmacological management of Kaposi's sarcoma.

P2860

Q24193874-A3F70894-B64D-4A90-94E9-900B35EC1819 Q24247970-93C631D4-E6DA-4B46-8F9B-A157DF3520D7 Q24628695-68E5F604-E381-439F-990D-6C9A2BA04B48 Q24635465-5DD35B8E-6375-4282-A385-AB403A7CE921 Q24802484-83DFC435-DC65-47FC-8E2B-7479DD53703C Q27000078-CFF38A8D-D862-4A54-B25E-298D52175D3B Q28547477-67373736-600A-4FD3-8F69-795BA746EF61 Q28818166-2DA9DCDF-8A11-4CE0-B274-1FD835823C4F Q30355939-8F4C8C1E-E1EA-4E13-A574-1A1E6B3F89FC Q30366990-54E706E9-5374-4EC6-9473-9BFF36907755 Q33343690-F814A0BD-3116-42CB-BC7E-40253E85A4CA Q33404677-F7F917A0-B0CB-4037-8A9F-225672FBF488 Q34045119-EDBF9B5A-097D-4463-BD86-A742D8615EB8 Q34168712-6BAF1ADF-A436-4A97-A747-EC99093587E5 Q34280875-781FF269-D839-485F-BA0A-B24FC31676AC Q34620787-C2005BA0-BC9E-43C5-819B-BF5652D8997C Q34726981-7BF45856-C31A-43D5-88F2-0C96EF86E06B Q34795330-7556A634-8B0A-4355-AB23-646996DF5A22 Q35051019-63418166-ECAD-46BA-B781-CC7CCE982D42 Q35551167-AED984D9-3AF0-42B6-937E-EED45445B99F Q35679856-A54BABC6-3F73-4877-960A-672959AF095F Q35779249-DCA60E60-CACE-4180-AEAF-E2FEF45E7444 Q36160333-A6985376-41F5-4A1D-933F-5E7202D1E3A4 Q36212921-874B3E61-DC4D-465B-99CA-B9A79D8EEBFD Q36236848-D7BB1A31-0DEF-4564-9D0B-FBB60EF74CDE Q36495946-293B179F-ADFA-4E7D-82F7-39770080AFC6 Q36520006-54C1314A-04F1-437D-82B0-A92E04EDBA86 Q36624187-5265576B-C75F-4F2F-B736-66444FC5C528 Q36791673-82140876-432A-47AE-96EC-D722000AEB1E Q36988072-E681F717-6296-4AF4-873C-FAF713C8FDA0 Q37004096-34552A12-D619-4BC1-853A-6F17BFBF6801 Q37059896-9AC84CA6-99A4-4D72-90DD-B3F7CCD99592 Q37467770-5F576D0A-EA8A-40FD-B107-330773E6E063 Q37476252-F9F4E994-0FD2-406D-A8FB-F6CAF9370060 Q37505000-850D2DE4-5D6C-4C9E-A6E8-241CFB9887EC Q37575499-B5EAE604-5C32-4778-9DFA-085E514A1973 Q37628536-90FE4667-C7EE-45EC-B03C-B884FF561AEF Q37689857-F63698E8-18B9-4199-942A-9DDC47C19314 Q37806235-350F5AAE-4017-45AD-8A51-931D28929CBF Q37868566-A2A9244F-15C5-4808-B008-1E429A915C63

P2860

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

http://www.wikidata.org/entity/Q34733886

description

1996 nî lūn-bûn

@nan

1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@ast

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@en

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@nl

type

label

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@ast

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@en

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@nl

prefLabel

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@ast

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@en

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@nl

P1433

Q34733886-D4E59ACE-0EAE-4752-866D-0E2B57CE0217

P1476

Q34733886-C6ACCEB6-69E6-43A4-A37B-BA18CF3A3644

P2093

Q34733886-034337CE-A45B-4BDD-BE1B-C57C2A951269

Q34733886-0864D7B2-A02A-4E03-9BCE-5EEA238A5026

Q34733886-11CE7F74-D788-49DA-A9CA-BF8FF465F7B7

Q34733886-1D6F4794-28F9-4FF4-B451-2B634300F490

Q34733886-2436B0F6-3A74-48CD-A63E-456039B3FAA6

Q34733886-26034D75-16D9-4710-A6FE-ACEE1A7316C7

Q34733886-3E7A44C0-4A5B-4921-9235-6F94BC2D0397

Q34733886-4A3942BE-E843-4C78-B3AC-A05BEBF4BD92

Q34733886-5ACD22F3-A2DA-4584-81DD-6A67F100737D

Q34733886-5AE727A1-1DCF-4489-8FEB-A5B965C9B1BA

P304

Q34733886-6D2D3EB2-0944-4484-8E6B-55A7B93C87BC

P31

Q34733886-D2DC4B82-CAF9-4284-83A5-E12EF8B2D5FE

P356

Q34733886-496BA937-9D55-4FB2-B121-372FCF061B42

P407

Q34733886-92899010-7C8A-4367-8715-04180D1FE99E

P433

Q34733886-EB1B9993-15B7-4E36-990B-1684A0B00B49

P478

Q34733886-E7C7538A-3F73-4436-AECD-47A9B78B50C6

P577

Q34733886-57B56519-B63C-4FF9-8578-921F437E65CC

P698

Q34733886-F3531230-6361-4CF6-AA3F-43674D805461

P921

Q34733886-B951F29F-DCB1-4927-901C-54A18B7CF187

P356

JCO.1996.14.8.2353

P1433

Journal of Clinical Oncology

P1476

Randomized phase III trial of ...... AIDS-related Kaposi's sarcoma.

@en

P2093

A M Myers

http://www.w3.org/2001/XMLSchema#string

C Sawka

http://www.w3.org/2001/XMLSchema#string

D T Scadden

http://www.w3.org/2001/XMLSchema#string

F Shepherd

http://www.w3.org/2001/XMLSchema#string

G Gonzales

http://www.w3.org/2001/XMLSchema#string

G M Mukwaya

http://www.w3.org/2001/XMLSchema#string

I Silverberg

http://www.w3.org/2001/XMLSchema#string

J H von Roenn

http://www.w3.org/2001/XMLSchema#string

J Wernz

http://www.w3.org/2001/XMLSchema#string

M C Pike

http://www.w3.org/2001/XMLSchema#string

P304

2353-2364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.1996.14.8.2353

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8708728

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial